Katrien Reynders

Board Member • Holland BIO

Katrien Reynders-Frederix is the former CEO of Pan Cancer T, a biotech developing TCR T-cell therapies for challenging solid tumours, and Board member of Holland Bio, an organisation representing the interests of the dutch biotech. Katrien has a great passion for translating breakthrough science into innovative treatments with commercial potential. Prior Pan Cancer T, she accumulated 20 years of experience in the biopharmaceutical industry from preclinical to market access, where she successfully led international drug development teams and global programs, particularly in the field of immune oncology. 


Also speaking

Eric Strati

Chief Executive Officer • Gift of Life Biologics

Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Giulia Agliardi

QC and Process Development Lead at the UCL CAR-T cell Programme, UCL Cancer Institute • UCL

Event Info


Pre-Day Events

Discover more about the Pre-Day Events taking place at Advanced Therapies Europe.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.